Filter results

Pharmaceutical Reports

By Geography
By Sector
By Publication Type
Showing
1-20 of 169
Germany: Election Primer

Germany: Election Primer

Germany will remain the most important political player in the eurozone, and a driver of economic growth in the region. The next coalition government will have a major impact on the tenor of German foreign ...
$580.00
Read More
Industry Hit List: Ranking Emerging Market Opportunities

Industry Hit List: Ranking Emerging Market Opportunities

The lack of a uniform growth driver for emerging markets, such as soaring commodity prices or a booming Chinese economy, means that economic performance will be more varied than in the past two decades. As ...
$795.00
Read More
The Year Ahead: Global Industries Outlook 2017 - Mid-Year Update

The Year Ahead: Global Industries Outlook 2017 - Mid-Year Update

External forces such as greater trade protectionism are creating more cautious investment decisions, but also opportunities for new alliances and regional partnerships to be created. Internal forces such as changes to the competitive landscapes of ...
$580.00
Read More
Algeria Pharmaceuticals & Healthcare Report

Algeria Pharmaceuticals & Healthcare Report

BMI View: Algeria's pharmaceutical and healthcare expenditure will continue to expand over the forecast period, creating renewed commercial and investment opportunities for drugmakers and health sector providers. The large and expanding population, as well ...
$1,345.00
Read More
Angola Pharmaceuticals & Healthcare Report

Angola Pharmaceuticals & Healthcare Report

BMI View: Growth in Angola's pharmaceutical market will be driven by the county's rapidly rising population and high disease burden. The government's moves to build new hospitals and expand existing ones will ...
$1,345.00
Read More
Argentina Pharmaceuticals & Healthcare Report

Argentina Pharmaceuticals & Healthcare Report

BMI View: Argentina will remain one of Latin America's most attractive markets to multinational pharmaceutical firms over the forecast period. This is supported by the relatively high spending per capita on medicine, as well ...
$1,345.00
Read More
Asia Pharmaceuticals & Healthcare Report

Asia Pharmaceuticals & Healthcare Report

BMI View : Commercial prospects are robust as the Asia Pacific's rising demand for treatments dovetails and reinforces with the financial constraints of payers to drive demand for lower cost drugs. Innovative medicines will continue ...
$1,345.00
Read More
Australia Pharmaceuticals & Healthcare Report

Australia Pharmaceuticals & Healthcare Report

BMI View: The listing of high-value pharmaceuticals on the Australian Pharmaceutical Benefit Scheme will remain challenging. While additional funding allocations to the scheme can be expected, these will be subject to negotiation, with authorities leveraging ...
$1,345.00
Read More
Austria Pharmaceuticals & Healthcare Report

Austria Pharmaceuticals & Healthcare Report

BMI View: Despite its small size Austria has a relatively developed pharmaceutical industry with both foreign and local drugmakers establishing manufacturing capacity in the country. Given the strong support from the state towards start-ups and ...
$1,345.00
Read More
Bahrain Pharmaceuticals & Healthcare Report

Bahrain Pharmaceuticals & Healthcare Report

BMI View: We expect a moderate increase in Bahraini medicine sales in 2017, which will gradually gain momentum over the long term. The demand for prescription drugs will be boosted by the eventual implementation of the ...
$1,345.00
Read More
Bangladesh Pharmaceuticals & Healthcare Report

Bangladesh Pharmaceuticals & Healthcare Report

BMI View: Bangladesh's pharmaceutical market will continue to post relatively high growth rates over the forecast period. However, low affordability levels and a poor operating environment will ensure that the country remains a high ...
$1,345.00
Read More
Belarus Pharmaceuticals & Healthcare Report

Belarus Pharmaceuticals & Healthcare Report

BMI View: Despite economic and political tensions, Belarus will continue to represent a market of considerable interest for foreign companies, both innovative and generic makers. The government's programme to reduce import reliance has led ...
$1,345.00
Read More
Belgium Pharmaceuticals & Healthcare Report

Belgium Pharmaceuticals & Healthcare Report

BMI View : With the victory French President Emmanuel Macron expected to bring out about much-needed reform to an ailing French economy, Belgium is widely expected to be one of the first to benefit from a ...
$1,345.00
Read More
Botswana Pharmaceuticals & Healthcare Report

Botswana Pharmaceuticals & Healthcare Report

BMI View: Botswana's pharmaceutical market will experience robust growth over the coming years. This is due to a growing commitment from the government to improve healthcare infrastructure in the country and to tackle the ...
$1,345.00
Read More
Brazil Pharmaceuticals & Healthcare Report

Brazil Pharmaceuticals & Healthcare Report

BMI View: The Brazilian pharmaceutical market has markedly declined in recent years on a US dollar-denominated basis due to the country's recession, limiting multinational drugmaker appetite. Despite the anticipated recovery in 2017, Brazil will remain ...
$1,345.00
Read More
Bulgaria Pharmaceuticals & Healthcare Report

Bulgaria Pharmaceuticals & Healthcare Report

BMI View: A number of the government's wide- reaching healthcare reform proposals have already been enacted, most notably its e-health system. In addition to this, the signing of the Cooperation Agreement between Bulgaria and ...
$1,345.00
Read More
Cambodia Pharmaceuticals & Healthcare Report

Cambodia Pharmaceuticals & Healthcare Report

BMI View: Cambodia's pharmaceutical spending will observe high value growth rates over the forecast period , driven by economic development and rising demand for medical treatment. However, the small drug market and low per capita ...
$1,345.00
Read More
Cameroon Pharmaceuticals & Healthcare Report

Cameroon Pharmaceuticals & Healthcare Report

BMI View : Cameroon's pharmaceutical and healthcare market will continue to expand over the forecast period on the back of sustained economic growth. We expect Cameroon to remain among the ten most attractive pharmaceutical markets ...
$1,345.00
Read More
Canada Pharmaceuticals & Healthcare Report

Canada Pharmaceuticals & Healthcare Report

BMI View: Canada's strong publicly funded healthcare system and stable political environment make for an attractive base for sales and manufacturing. We forecast steady market growth - pricing and reimbursement pressures represent the main ...
$1,345.00
Read More
Chile Pharmaceuticals & Healthcare Report

Chile Pharmaceuticals & Healthcare Report

BMI View: The non-profit group Knowledge Ecology International has put pressure on the Chilean government to use its authority to grant compulsory licences for the branded prostate cancer drug, enzalutamide (Xtandi) and on sofosbuvir-based combination ...
$1,345.00
Read More
Showing
1-20 of 169